Location: Taichung
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Taichung
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor ( Phase 1 · Taichung Veteran General Hospital · Acepodia Biotech, Inc. · NCT06415487 Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav Phase 3 · China Medical University Hospital · Pfizer · NCT05020236 Taiwan Interstitial Lung Disease Multi-center Investigation and Registry Phase N/A · Taichung Veterans General Hospital · Taichung Veterans General Hospital · NCT06476470 Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · China Medical University Hospital · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Taichung Veterans General Hospital · Pfizer · NCT07028853 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer Phase 3 · Taichung Veterans General Hospital · Daiichi Sankyo · NCT07022483 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias Phase 1/Phase 2 · China Medical University Hospital · Lin BioScience, Inc · NCT05756322 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Taichung Veterans General Hospital · Pfizer · NCT06758401 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease Phase 2 · China Medical University Hospital · Boehringer Ingelheim · NCT07355296 Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic NA · Tungs' Taichung Metroharbour Hospital · Tungs' Taichung Metroharbour Hospital · NCT07443280 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia Phase 2 · Department of Psychiatry, China Medical University Hospital · China Medical University Hospital · NCT06021197 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Chung Shan Medical University Hospital · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit Phase 1/Phase 2 · Local Institution - 0032 · Bristol-Myers Squibb · NCT07291076 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Taichung Veterans General Hospital · Amgen · NCT07037433 Optimized Diagnosis and Precision Medicine of MODY Phase N/A · Taichung veterans general hospital · Taichung Veterans General Hospital · NCT06111833 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Phase 2 · China Medical University Hospital · Eli Lilly and Company · NCT07415044 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena Phase 3 · Taichung Veterans General Hospital ( Site 3304) · Merck Sharp & Dohme LLC · NCT07216703 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut Phase 2/Phase 3 · China Medical University Hospital /ID# 256764 · AbbVie · NCT06109272 Mirror Therapy and Augmented Reality in Stroke Rehabilitation NA · Fongyuan Hospital, Ministry of Health and Welfare · National Taiwan University Hospital · NCT05993091 Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness. NA · Taichung Veterans Genetal Hospital · Taichung Veterans General Hospital · NCT07378319 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · Chung Shan Medical University Hospital · Eli Lilly and Company · NCT06890598 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child Phase 3 · Taichung Veterans General Hospital · Bayer · NCT07192952 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight Phase 3 · China Medical University Hospital · Eli Lilly and Company · NCT07369011 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie Phase 3 · China Medical University Hospital · Pfizer · NCT05895786 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ Phase 3 · Taichung Veterans General Hospital · Pfizer · NCT07144280 A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A Phase 3 · Taichung Veterans General Hospital · Hoffmann-La Roche · NCT07416526
Look up another city
Look up another condition